Evidence map›Paper›PMID 41815777›Full record

SynthesisFrontiers in surgery2026

Molecular cartilage pathology following anterior cruciate ligament reconstruction: a systematic review of MRI studies.

Abdulmajeed Alfayyadh

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Abdulmajeed AlfayyadhDepartment of Physical Therapy and Health Rehabilitation, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Anterior cruciate ligament (ACL) injury increases the risk of post-traumatic osteoarthritis. Although ACL reconstruction (ACLR) restores mechanical stability, cartilage matrix abnormalities may persist and can be detected using quantitative and compositional magnetic resonance imaging (MRI). Objectives: To synthesize MRI evidence on tibiofemoral cartilage compositional changes after ACLR, identify factors associated with worse cartilage outcomes, and summarize methodological quality and limitations of the evidence. Methods: Embase, PubMed, Web of Science, Scopus, and Cochrane Library were searched for studies published between 2000 and 2025 that evaluated tibiofemoral cartilage after ACLR using quantitative or compositional MRI. Two reviewers performed screening, data extraction, and risk-of-bias assessment. Meta-analysis was restricted to outcomes with sufficient comparability across studies; other outcomes were synthesized narratively. Results: Thirty-five studies were included. Across cohorts, ACLR knees generally demonstrated elevated cartilage T2 relaxation times and elevated T1 Limitations: Considerable variability in MRI protocols, regions of interest, and reporting limited pooling. Several studies may represent overlapping cohorts, and many analyses were underpowered. Conclusion: MRI evidence indicates that biochemical cartilage abnormalities commonly persist after ACLR, particularly in the medial tibiofemoral compartment. Standardized imaging protocols and long-term longitudinal studies linking MRI biomarkers to clinical outcomes are needed. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251156314, PROSPERO CRD420251156314.

Indexed as

ACL reconstructioncompositional MRIpost-traumatic osteoarthritisquantitative MRIT1rhoT2 mappingtibiofemoral cartilageUTE-T2*

Identifiers

PMID41815777
PMCPMC12971894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.